Jason R. Neil, Ph.D. - Publications

Affiliations: 
2008 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Pharmacology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Hackel BJ, Neil JR, White FM, Wittrup KD. Epidermal growth factor receptor downregulation by small heterodimeric binding proteins. Protein Engineering, Design & Selection : Peds. 25: 47-57. PMID 22160867 DOI: 10.1093/protein/gzr056  0.56
2011 Tian M, Neil JR, Schiemann WP. Transforming growth factor-β and the hallmarks of cancer. Cellular Signalling. 23: 951-62. PMID 20940046 DOI: 10.1016/j.cellsig.2010.10.015  0.84
2010 Spangler JB, Neil JR, Abramovitch S, Yarden Y, White FM, Lauffenburger DA, Wittrup KD. Combination antibody treatment down-regulates epidermal growth factor receptor by inhibiting endosomal recycling. Proceedings of the National Academy of Sciences of the United States of America. 107: 13252-7. PMID 20616078 DOI: 10.1073/pnas.0913476107  0.56
2009 Neil JR, Tian M, Schiemann WP. X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-{beta}-mediated nuclear factor-{kappa}B activation during breast cancer progression. The Journal of Biological Chemistry. 284: 21209-17. PMID 19531477 DOI: 10.1074/jbc.M109.018374  0.84
2008 Neil JR, Johnson KM, Nemenoff RA, Schiemann WP. Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms. Carcinogenesis. 29: 2227-35. PMID 18725385 DOI: 10.1093/carcin/bgn202  0.84
2008 Neil JR, Schiemann WP. Altered TAB1:I kappaB kinase interaction promotes transforming growth factor beta-mediated nuclear factor-kappaB activation during breast cancer progression. Cancer Research. 68: 1462-70. PMID 18316610 DOI: 10.1158/0008-5472.CAN-07-3094  0.56
2006 Galliher AJ, Neil JR, Schiemann WP. Role of transforming growth factor-beta in cancer progression. Future Oncology (London, England). 2: 743-63. PMID 17155901 DOI: 10.2217/14796694.2.6.743  0.84
2006 Neil JR, Galliher AJ, Schiemann WP. TGF-beta in cancer and other diseases. Future Oncology (London, England). 2: 185-9. PMID 16563087 DOI: 10.2217/14796694.2.2.185  0.84
2006 Albig AR, Neil JR, Schiemann WP. Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Research. 66: 2621-9. PMID 16510581 DOI: 10.1158/0008-5472.CAN-04-4096  0.56
2005 Sokol JP, Neil JR, Schiemann BJ, Schiemann WP. The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta. Breast Cancer Research : Bcr. 7: R844-53. PMID 16168131 DOI: 10.1186/bcr1312  0.84
2003 Schiemann BJ, Neil JR, Schiemann WP. SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system. Molecular Biology of the Cell. 14: 3977-88. PMID 14517312 DOI: 10.1091/mbc.E03-01-0001  0.84
Show low-probability matches.